$DHR supplies life-science, diagnostic and bioprocessing tools. The next scheduled marker is Q3 results on Oct. 21, which will give investors a fresh read on de

$DHR supplies life-science, diagnostic and bioprocessing tools. The next scheduled marker is Q3 results on Oct. 21, which will give investors a fresh read on demand across those end markets. At $224.49, price is above the $202.75 EMA and $199.62 WMA, with RSI 61.5 and positive MACD above its signal…